Caisson Biotech, L.L.C. Company Profile
Caisson Biotech is a wholly owned subsidiary of Heparinex, L.L.C. Caisson uses novel, heparosan-based conjugates to enhance the therapeutic properties of pharmaceuticals by increasing product half-life, reducing immunogenicity, and increasing stability. This newly invented drug delivery platform was developed by Chief Scientist and Professor Dr. Paul L. DeAngelis at the University of Oklahoma Health Sciences Center.
News Articles
Austin, TX (PRWEB) May 01, 2013 Emergent Technologies, Inc. and portfolio company, Caisson Biotech, LLC, developer of the novel HEPtuneTM drug delivery system, are teaming with Seton Healthcare Fam...
Caisson Biotech, LLC Appoints Biotechnology Veteran Glenn Nedwin CEO and President
Caisson Biotech, L.L.C., a biopharmaceutical company with the patented drug delivery technology HEPtuneTM, announced today that it has appointed Glenn E. Nedwin, Ph....
Emergent, Caisson Collaborating to Optimize Heparosan Drug Delivery Platform
The Entrepreneurial Diaspora Enabled By Biotech M&A
The recycling of equity capital through realized returns is a critically important element of biotech investing. When public biotech companies get bought, like Genentech by Roche, or smaller deals l...
Biotech crops gaining worldwide acceptance
For the first time since the introduction of biotech crops almost two decades ago, developing countries grew biotech crops on more land than in industrialized countries in 2012, according to a report...
Agila Biotech to Set Up Biotech Facility at Malaysia's Bio-XCell Ecosystem
Agila Biotech aims for the R&D and manufacturing facilities to be operational by end-2014.
Übernahme von BB Biotech abgesagt
Die Biotech-Beteiligungsgesellschaft BB Biotech bleibt eigenständig. Ein Übernahmeversuch der...
More Farmers Around the World Plant Biotech Crops
ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record 17...
Drugs and Medications
Ocufresh [Taiwan Biotech Co, Ltd]
Minidrops [Taiwan Biotech Co, Ltd]
Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]
Drug Fact
Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]
Drug Fact
Stelara [Janssen Biotech, Inc.]
These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...
PubMed Articles
Biotech 101: An Educational Outreach Program in Genetics and Biotechnology.
Recent advances in research and biotechnology are making genetics and genomics increasingly relevant to the lives and health of the general public. For the public to make informed healthcare and publi...
Industry progress report on neuro-oncology: a biotech update.
With steadily rising revenue and large numbers of clinical trials utilizing novel treatment strategies, the field of neuro-oncology is at the core of the growing cancer therapy industry. In June 2012,...
Clinical Trials
Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides
Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition
The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition
The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...
This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant...
Companies
Caisson Biotech is a wholly owned subsidiary of Heparinex, L.L.C. Caisson uses novel, heparosan-based conjugates to enhance the therapeutic properties of pharmaceuticals by increa...
Caisson Biotech is a wholly-owned subsidiary of Heparinex, L.L.C. Caisson uses novel, heparosan-based conjugates to enhance the therapeutic properties of pharmaceuticals by increa...
The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...
Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...
M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...
More Information about "Caisson Biotech, L.L.C." on BioPortfolio
We have published hundreds of Caisson Biotech, L.L.C. news stories on BioPortfolio along with dozens of Caisson Biotech, L.L.C. Clinical Trials and PubMed Articles about Caisson Biotech, L.L.C. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Caisson Biotech, L.L.C. Companies in our database. You can also find out about relevant Caisson Biotech, L.L.C. Drugs and Medications on this site too.
